{
    "Trade/Device Name(s)": [
        "ID NOW Influenza A & B 2",
        "Alere\u2122 i Influenza A & B 2",
        "ID NOW Flu 2",
        "Alere\u2122 i Flu 2",
        "Alere\u2122 Influenza A & B 2"
    ],
    "Submitter Information": "Alere Scarborough, Inc.",
    "510(k) Number": "K190204",
    "Predicate Device Reference 510(k) Number(s)": [
        "K173932"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "OZE",
        "OCC",
        "OOI"
    ],
    "Summary Letter Date": "March 4, 2019",
    "Summary Letter Received Date": "March 6, 2019",
    "Submission Date": "January 31, 2019",
    "Regulation Number(s)": [
        "21 CFR 866.3980",
        "21 CFR 862.2570"
    ],
    "Regulation Name(s)": [
        "Respiratory viral panel multiplex nucleic acid assay",
        "Instrumentation for Clinical Multiplex Test Systems"
    ],
    "Analyte Class(es)": [
        "virology",
        "microbiology"
    ],
    "Analyte(s)": [
        "Influenza A viral RNA",
        "Influenza B viral RNA"
    ],
    "Specimen Type(s)": [
        "Nasal swab",
        "Nasopharyngeal swab",
        "Nasal swab eluted in viral transport media",
        "Nasopharyngeal swab eluted in viral transport media"
    ],
    "Specimen Container(s)": [
        "Sample Receiver (single use, disposable)"
    ],
    "Instrument(s)/Platform(s)": [
        "ID NOW Instrument",
        "Alere\u2122 Universal Printer (accessory)"
    ],
    "Method(s)/Technology(ies)": [
        "Isothermal nucleic acid amplification",
        "Fluorescent molecular beacon detection"
    ],
    "Methodologies": [
        "Molecular amplification",
        "Qualitative detection"
    ],
    "Submission Type(s)": [
        "Assay",
        "Instrument",
        "System",
        "Reagent",
        "Cartridge",
        "Component",
        "Reader"
    ],
    "Document Summary": "FDA 510(k) summary for ID NOW Influenza A & B 2 rapid molecular assay using isothermal nucleic acid amplification for detection of influenza A and B RNA",
    "Indications for Use Summary": "Qualitative detection and discrimination of influenza A and B viral RNA in nasal or nasopharyngeal swabs and corresponding transport media from patients with respiratory infection symptoms, as an aid in differential diagnosis in conjunction with clinical and epidemiological risk factors.",
    "fda_folder": "Microbiology"
}